The World Trade Organisation's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is an international legal agreement between all WTO members (WTO). It defines minimum requirements for national governments to regulate various forms of Intellectual Property (IP) as they apply to citizens of other WTO member countries. It is a crucial topic in the Economy syllabus for the UPSC Examination. This is a significant topic for the UPSC exam from a variety of aspects, including economics, international relations, current affairs, and so on.
|
Table of Contents |

|
|
|
|---|---|
| Intellectual Property Rights | Take-Out Financing |
| National Treatment | Agreement on Agriculture (AoA) |
| General Agreement on Trade in Services (GATS) | Most Favoured Nation (MFN) |
The categories of rights protected under the TRIPS agreement are as follows





In response to the COVID-19 pandemic, India and South Africa proposed to the World Trade Organization (WTO) in October 2020 that the TRIPS Agreement (which included patent protection for pharmaceutical products, including COVID vaccines) be waived for COVID vaccines, medicines, and diagnostics for the duration of the pandemic, in order to make COVID vaccines and drugs available to the greatest number of people possible.
TRIPS is crucial in promoting trade in knowledge and creativity, resolving trade disputes over intellectual property, and guaranteeing WTO members the freedom to pursue their domestic policy goals. Above all, TRIPS places the IP system in the context of innovation, technological transfer, and the public good.
Q1: What does TRIPS stand for?
Answer: TRIPS stands for Trade-Related Aspects of Intellectual Property Rights. It is an international agreement that establishes minimum standards for intellectual property protection among World Trade Organization (WTO) members.
Q2: When was the TRIPS Agreement introduced?
Answer: The TRIPS Agreement was introduced in 1994 during the Uruguay Round of negotiations under the General Agreement on Tariffs and Trade (GATT).
Q3: What are the key objectives of the TRIPS Agreement?
Answer: The key objectives of the TRIPS Agreement include promoting effective and adequate protection of intellectual property rights, ensuring that measures and procedures to enforce these rights do not become barriers to legitimate trade, and promoting technological innovation.
Q4: How does TRIPS impact developing countries like India?
Answer: TRIPS impacts developing countries by requiring them to adopt stronger intellectual property protections, which can lead to increased foreign investment and technology transfer but may also limit access to affordable medicines and hinder local innovation.
Q5: What are the criticisms of the TRIPS Agreement?
Answer: The criticisms of the TRIPS Agreement include concerns over its potential to prioritize corporate interests over public health, restrict access to essential medicines, and hinder local industries' ability to innovate due to stringent patent protections.
A) To promote free trade without restrictions
B) To protect intellectual property rights globally
C) To eliminate tariffs on international trade
D) To regulate foreign direct investment
Answer: (B) See the Explanation
A) World Health Organization (WHO)
B) United Nations (UN)
C) World Trade Organization (WTO)
D) International Monetary Fund (IMF)
Answer: (C) See the Explanation
A) Elimination of all patents
B) Protection of trademarks only
C) Extension of patent protection to 20 years
D) Increased patent fees
Answer: (C) See the Explanation
A) Information Technology
B) Agriculture
C) Pharmaceuticals
D) Textile
Answer: (C) See the Explanation
A) By mandating technology transfer agreements
B) By discouraging foreign investments
C) By promoting local production
D) By encouraging innovation
Answer: (A) See the Explanation
Q1. Analyze the implications of the TRIPS Agreement on the Indian economy.
Answer: The TRIPS Agreement has profound implications for the Indian economy, particularly in sectors like pharmaceuticals and agriculture. On one hand, it aims to enhance the protection of intellectual property rights, encouraging foreign direct investment and technology transfer, which can spur innovation and economic growth. On the other hand, stringent patent laws can limit access to essential medicines, impacting public health. The pharmaceutical sector, previously characterized by a robust generic market, has faced challenges in adapting to new patent regulations. This has led to concerns about the affordability of medicines, especially for lower-income populations. Additionally, the agreement has prompted Indian industries to innovate and strengthen their intellectual property framework. Overall, while TRIPS provides opportunities for economic advancement, it also necessitates a balanced approach to ensure that public welfare is not compromised in the pursuit of intellectual property rights.
Q2. Discuss the challenges that the TRIPS Agreement poses for developing countries, particularly India.
Answer: The TRIPS Agreement poses several challenges for developing countries like India, primarily due to the need to align domestic laws with international standards of intellectual property protection. This alignment often results in increased costs for compliance and legal infrastructure development. One significant challenge is the impact on access to medicines, as patent protections can lead to higher drug prices, making healthcare less affordable for many. Additionally, the emphasis on patenting can stifle local innovation, as small enterprises may lack the resources to navigate the complexities of intellectual property law. The agricultural sector also faces challenges, particularly regarding traditional knowledge and biodiversity, as TRIPS can enable biopiracy—where companies patent indigenous knowledge without proper recognition or compensation to local communities. Furthermore, developing countries may struggle with enforcing intellectual property rights due to inadequate legal frameworks and enforcement mechanisms. Balancing the need for protection with the promotion of public welfare remains a critical challenge.
Q3. Evaluate the criticisms of the TRIPS Agreement and suggest reforms that could address these concerns.
Answer: Criticisms of the TRIPS Agreement primarily center around its perceived prioritization of corporate interests over public health and welfare. Critics argue that the stringent intellectual property protections can hinder access to affordable medicines and limit the ability of local industries to innovate. To address these concerns, several reforms could be implemented. First, there could be greater flexibility in the agreement regarding public health exceptions, allowing countries to bypass patent protections in times of health crises. Second, promoting local innovation through support for research and development in the pharmaceutical sector can help mitigate the adverse effects of stringent patent laws. Third, a more robust mechanism for recognizing and protecting traditional knowledge and biodiversity could prevent biopiracy and empower indigenous communities. Finally, fostering international cooperation to ensure fair technology transfer to developing nations can help balance the scales between developed and developing countries, promoting sustainable economic growth without compromising public health.
Question: Examine the impact of the TRIPS Agreement on India's pharmaceutical sector.
Answer: The TRIPS Agreement significantly impacts India's pharmaceutical sector, primarily by imposing stringent patent protections that require compliance with international intellectual property standards. Prior to TRIPS, India was a leader in producing generic medicines, enabling access to affordable healthcare for millions. The agreement mandates a minimum patent protection of 20 years, which restricts the production of generic drugs and consequently raises prices for essential medications. This has led to public health concerns, especially during health crises where access to affordable medicines is crucial. While TRIPS encourages foreign investment and technology transfer, the pharmaceutical industry faces the challenge of balancing compliance with innovation. As a response, Indian companies have begun to focus on research and development, yet the transition remains fraught with difficulties. Overall, while TRIPS aims to enhance the global competitiveness of India's pharmaceutical sector, it also poses significant risks to public health accessibility.
Question: Critically analyze the arguments for and against the TRIPS Agreement in the context of developing nations.
Answer: The TRIPS Agreement presents a complex set of arguments for and against its implementation in developing nations. Proponents argue that it fosters an environment conducive to innovation, attracting foreign direct investment and facilitating technology transfer, thereby stimulating economic growth. Enhanced intellectual property protection is seen as a pathway to strengthening local industries, encouraging them to innovate and compete globally. However, critics argue that TRIPS disproportionately benefits multinational corporations at the expense of public welfare. In many developing countries, stringent patent laws can restrict access to essential medicines, creating barriers to healthcare for marginalized populations. Furthermore, the requirement for robust intellectual property enforcement can strain local legal systems and divert resources away from critical development areas. The debate surrounding TRIPS highlights the need for a balanced approach that safeguards both intellectual property rights and public health needs, advocating for reforms that consider the unique challenges faced by developing nations while promoting equitable economic growth.
Download the PREPP App and attempt FREE IAS Exam Mock Tests and get complete study material!
Comments